Published in Eur J Pediatr on January 01, 1985
Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child (1990) 2.59
Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg (1996) 1.07
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit. Clin Perinatol (2012) 0.77
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod (2002) 2.55
Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics (1999) 1.83
Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2001) 1.73
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Calcium homeostasis and hypercalciuria in hyperprostaglandin E syndrome. J Pediatr (1992) 1.58
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon (1972) 1.49
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
Negative ion chemical ionization gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry of prostanoid pentafluorobenzyl ester/methoxime/trimethylsilyl ether derivatives. Biomed Environ Mass Spectrom (1988) 1.35
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res (2000) 1.27
Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet (2000) 1.27
Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr (1985) 1.17
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Mutations in the ROMK gene in antenatal Bartter syndrome are associated with impaired K+ channel function. Biochem Biophys Res Commun (1997) 1.07
Gender-specific health behaviors of German university students predict the interest in campus health promotion. Health Promot Int (2001) 1.06
Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. BMJ (1988) 1.05
Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics (2001) 1.02
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Eur J Clin Pharmacol (1994) 1.00
Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr (2001) 1.00
Role of atrial natriuretic peptide in sodium homeostasis in premature infants. J Pediatr (1986) 0.99
Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. J Pharmacol Exp Ther (1997) 0.99
Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther (1975) 0.99
Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies. Prostaglandins (1976) 0.98
On the origin of the invasive olives (Olea europaea L., Oleaceae). Heredity (Edinb) (2007) 0.98
Detection of bacteriuria. Lancet (1970) 0.98
Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit. Prostaglandins (1977) 0.97
Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol (1999) 0.97
Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr (1983) 0.96
Pharmacotyping of hypokalaemic salt-losing tubular disorders. Acta Physiol Scand (2004) 0.95
Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr (1994) 0.95
Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol (2001) 0.94
Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids (1996) 0.94
Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro. Nature (1977) 0.94
Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res (1980) 0.94
[Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee]. Z Rheumatol (2000) 0.92
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection. Eur J Cancer (2001) 0.92
Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int (1987) 0.92
Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus. Eur J Pediatr (1983) 0.91
Arteriovenous angioma of the vein of Galen causing cardiac failure in the neonate. Report on clinical and pathological findings in two cases. Neuropediatrics (1983) 0.91
Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs. Bone (1999) 0.91
Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis (1997) 0.91
Atrial natriuretic peptide and patent ductus arteriosus in preterm infants. Arch Dis Child (1987) 0.89
Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E-syndrome. Kidney Int (1993) 0.89
Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus. Pediatr Res (1984) 0.88
Cyclic adenosine monophosphate in phagocytizing granulocytes and alveolar macrophages. J Cell Biol (1973) 0.88
A hyperprostaglandin E syndrome mutation in Kir1.1 (renal outer medullary potassium) channels reveals a crucial residue for channel function in Kir1.3 channels. J Biol Chem (1998) 0.87
Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors. Trans Assoc Am Physicians (1976) 0.87
Virilizing hepatoblastoma--significance of alpha-1-fetoprotein and human chorionic gonadotropin as tumor markers in diagnosis and follow-up. Eur J Pediatr (1981) 0.87
Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma. Br J Cancer (1980) 0.87
Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression. Pflugers Arch (2001) 0.86
Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet J Rare Dis (2006) 0.86
Prolonged indomethacin treatment in preterm infants with symptomatic patent ductus arteriosus: efficacy, drug level monitoring, and patient selection. Eur J Pediatr (1987) 0.85
New approaches for genotyping of Helicobacter pylori based on amplification of polymorphisms in intergenic DNA regions and at the insertion site of the cag pathogenicity island. Med Microbiol Immunol (2000) 0.85
Bronchopulmonary dysplasia in premature infants. A radiological and pathological correlation. Pediatr Radiol (1977) 0.85
Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusion. Br J Clin Pharmacol (1995) 0.84
Cutaneous malignant melanoma in women and the role of oral contraceptives. Br J Dermatol (1998) 0.84
Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr (1996) 0.84
[Neonatal information system I: computer-adapted pregnancy and birth record (author's transl)]. Z Geburtshilfe Perinatol (1975) 0.84
Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies. J Pediatr (2001) 0.83
Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon. J Pharmacol Exp Ther (2000) 0.83
Determination of peripheral plasma prostanoid concentration: an unreliable index of 'in vivo' prostanoid activity. Eur J Clin Pharmacol (1986) 0.83
Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf (2005) 0.83
Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Biol Mass Spectrom (1994) 0.83
In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants. J Inherit Metab Dis (1981) 0.82
Learning cyclic signaling pathway structures while minimizing data requirements. Pac Symp Biocomput (2009) 0.82
Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome. Pediatr Pharmacol (New York) (1982) 0.82
Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome. Kidney Int (2000) 0.82
Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry. J Chromatogr (1985) 0.82
Gitelman's syndrome is genetically distinct from other forms of Bartter's syndrome. Pediatr Nephrol (1996) 0.82
Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus. Biochem Biophys Res Commun (1994) 0.81
The molecular genetic approach to "Bartter's syndrome". J Mol Med (Berl) (1998) 0.81
Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol (1995) 0.81
A common NKCC2 mutation in Costa Rican Bartter's syndrome patients: evidence for a founder effect. J Am Soc Nephrol (1997) 0.81
Do we need another NSAID instead of indomethacin for treatment of ductus arteriosus in preterm infants? Acta Paediatr (2003) 0.80
Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome. Klin Wochenschr (1978) 0.80
Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans. J Mass Spectrom (1997) 0.80
Localization of the prostacyclin receptor in human kidney. Kidney Int (1998) 0.80
Lipoblastoma and lipoblastomatosis: a report of two cases and review of the literature. Eur J Pediatr Surg (2001) 0.80
Systemic air embolism in the respiratory distress syndrome of the newborn. Pediatr Radiol (1979) 0.79
Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. Acta Paediatr (1992) 0.79
Antenatal Bartter syndrome with sensorineural deafness: refinement of the locus on chromosome 1p31. Nephrol Dial Transplant (2000) 0.79
[Infusion-associated kidney and liver failure in undiagnosed hereditary fructose intolerance]. Dtsch Med Wochenschr (1983) 0.79
Aortic flow velocity curves in the diagnosis and the followup of symptomatic patent ductus arteriosus in preterm infants during therapeutic interventions. Pediatr Pharmacol (New York) (1983) 0.78
Pharmacologically active levels of PGE1 in neonates with congenital heart disease. Acta Paediatr Scand (1989) 0.78
Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy. Pediatr Res (1990) 0.78
Prostaglandins and renin release studies in the isolated perfused rat kidney. Prog Biochem Pharmacol (1980) 0.78
Intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr (1986) 0.78
The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome. Acta Physiol Scand (2004) 0.78
Group B streptococci: a new threat to the newborn. Eur J Pediatr (1977) 0.78
Determination of free and glucuronide conjugated 20-hydroxyarachidonic acid (20-HETE) in urine by gas chromatography/negative ion chemical ionization mass spectrometry. Prostaglandins Leukot Essent Fatty Acids (2000) 0.77
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. Clin Pharmacol Ther (2001) 0.77
[Studies of an improved L-amino acid solution for infusion therapy in childhood]. Monatsschr Kinderheilkd (1977) 0.77